ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.

Ahmad Karzoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.